nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Gastrointestinal tract irritation—Capecitabine—stomach cancer	0.0535	0.0535	CcSEcCtD
Metaxalone—Drowsiness—Mitomycin—stomach cancer	0.0367	0.0367	CcSEcCtD
Metaxalone—Leukopenia—Floxuridine—stomach cancer	0.0328	0.0328	CcSEcCtD
Metaxalone—Anaphylactic shock—Floxuridine—stomach cancer	0.0299	0.0299	CcSEcCtD
Metaxalone—Leukopenia—Mitomycin—stomach cancer	0.0257	0.0257	CcSEcCtD
Metaxalone—Hypersensitivity—Floxuridine—stomach cancer	0.022	0.022	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Irinotecan—stomach cancer	0.0214	0.0214	CcSEcCtD
Metaxalone—Somnolence—Mitomycin—stomach cancer	0.0208	0.0208	CcSEcCtD
Metaxalone—Vomiting—Floxuridine—stomach cancer	0.019	0.019	CcSEcCtD
Metaxalone—Irritability—Fluorouracil—stomach cancer	0.0189	0.0189	CcSEcCtD
Metaxalone—Rash—Floxuridine—stomach cancer	0.0188	0.0188	CcSEcCtD
Metaxalone—Dermatitis—Floxuridine—stomach cancer	0.0188	0.0188	CcSEcCtD
Metaxalone—Headache—Floxuridine—stomach cancer	0.0187	0.0187	CcSEcCtD
Metaxalone—Nausea—Floxuridine—stomach cancer	0.0177	0.0177	CcSEcCtD
Metaxalone—Jaundice—Irinotecan—stomach cancer	0.0156	0.0156	CcSEcCtD
Metaxalone—Dizziness—Mitomycin—stomach cancer	0.0155	0.0155	CcSEcCtD
Metaxalone—Haemolytic anaemia—Capecitabine—stomach cancer	0.0153	0.0153	CcSEcCtD
Metaxalone—Vomiting—Mitomycin—stomach cancer	0.0149	0.0149	CcSEcCtD
Metaxalone—Rash—Mitomycin—stomach cancer	0.0148	0.0148	CcSEcCtD
Metaxalone—Dermatitis—Mitomycin—stomach cancer	0.0148	0.0148	CcSEcCtD
Metaxalone—Headache—Mitomycin—stomach cancer	0.0147	0.0147	CcSEcCtD
Metaxalone—Nausea—Mitomycin—stomach cancer	0.0139	0.0139	CcSEcCtD
Metaxalone—Irritability—Capecitabine—stomach cancer	0.0132	0.0132	CcSEcCtD
Metaxalone—Abdominal discomfort—Capecitabine—stomach cancer	0.0115	0.0115	CcSEcCtD
Metaxalone—Leukopenia—Irinotecan—stomach cancer	0.0112	0.0112	CcSEcCtD
Metaxalone—Jaundice—Docetaxel—stomach cancer	0.0108	0.0108	CcSEcCtD
Metaxalone—Leukopenia—Fluorouracil—stomach cancer	0.0107	0.0107	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Methotrexate—stomach cancer	0.0107	0.0107	CcSEcCtD
Metaxalone—Jaundice—Capecitabine—stomach cancer	0.0104	0.0104	CcSEcCtD
Metaxalone—Anaphylactic shock—Irinotecan—stomach cancer	0.0102	0.0102	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Epirubicin—stomach cancer	0.00997	0.00997	CcSEcCtD
Metaxalone—Irritability—Methotrexate—stomach cancer	0.00985	0.00985	CcSEcCtD
Metaxalone—Anaphylactic shock—Fluorouracil—stomach cancer	0.00975	0.00975	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00923	0.00923	CcSEcCtD
Metaxalone—Somnolence—Irinotecan—stomach cancer	0.00905	0.00905	CcSEcCtD
Metaxalone—Somnolence—Fluorouracil—stomach cancer	0.00866	0.00866	CcSEcCtD
Metaxalone—Abdominal discomfort—Methotrexate—stomach cancer	0.00855	0.00855	CcSEcCtD
Metaxalone—Drowsiness—Methotrexate—stomach cancer	0.00795	0.00795	CcSEcCtD
Metaxalone—Leukopenia—Docetaxel—stomach cancer	0.00772	0.00772	CcSEcCtD
Metaxalone—Hypersensitivity—Irinotecan—stomach cancer	0.0075	0.0075	CcSEcCtD
Metaxalone—Leukopenia—Capecitabine—stomach cancer	0.00747	0.00747	CcSEcCtD
Metaxalone—Drowsiness—Epirubicin—stomach cancer	0.00744	0.00744	CcSEcCtD
Metaxalone—Jaundice—Epirubicin—stomach cancer	0.00725	0.00725	CcSEcCtD
Metaxalone—Hypersensitivity—Fluorouracil—stomach cancer	0.00718	0.00718	CcSEcCtD
Metaxalone—Anaphylactic shock—Docetaxel—stomach cancer	0.00703	0.00703	CcSEcCtD
Metaxalone—Pruritus—Fluorouracil—stomach cancer	0.0069	0.0069	CcSEcCtD
Metaxalone—Drowsiness—Doxorubicin—stomach cancer	0.00688	0.00688	CcSEcCtD
Metaxalone—Dizziness—Irinotecan—stomach cancer	0.00673	0.00673	CcSEcCtD
Metaxalone—Jaundice—Doxorubicin—stomach cancer	0.00671	0.00671	CcSEcCtD
Metaxalone—Vomiting—Irinotecan—stomach cancer	0.00647	0.00647	CcSEcCtD
Metaxalone—Dizziness—Fluorouracil—stomach cancer	0.00645	0.00645	CcSEcCtD
Metaxalone—Rash—Irinotecan—stomach cancer	0.00642	0.00642	CcSEcCtD
Metaxalone—Dermatitis—Irinotecan—stomach cancer	0.00641	0.00641	CcSEcCtD
Metaxalone—Headache—Irinotecan—stomach cancer	0.00638	0.00638	CcSEcCtD
Metaxalone—Somnolence—Docetaxel—stomach cancer	0.00625	0.00625	CcSEcCtD
Metaxalone—Vomiting—Fluorouracil—stomach cancer	0.0062	0.0062	CcSEcCtD
Metaxalone—Rash—Fluorouracil—stomach cancer	0.00615	0.00615	CcSEcCtD
Metaxalone—Dermatitis—Fluorouracil—stomach cancer	0.00614	0.00614	CcSEcCtD
Metaxalone—Headache—Fluorouracil—stomach cancer	0.00611	0.00611	CcSEcCtD
Metaxalone—Nausea—Irinotecan—stomach cancer	0.00604	0.00604	CcSEcCtD
Metaxalone—Nausea—Fluorouracil—stomach cancer	0.00579	0.00579	CcSEcCtD
Metaxalone—Tension—Epirubicin—stomach cancer	0.00571	0.00571	CcSEcCtD
Metaxalone—Nervousness—Epirubicin—stomach cancer	0.00565	0.00565	CcSEcCtD
Metaxalone—Leukopenia—Methotrexate—stomach cancer	0.00556	0.00556	CcSEcCtD
Metaxalone—Tension—Doxorubicin—stomach cancer	0.00528	0.00528	CcSEcCtD
Metaxalone—Nervousness—Doxorubicin—stomach cancer	0.00522	0.00522	CcSEcCtD
Metaxalone—Leukopenia—Epirubicin—stomach cancer	0.0052	0.0052	CcSEcCtD
Metaxalone—Hypersensitivity—Docetaxel—stomach cancer	0.00518	0.00518	CcSEcCtD
Metaxalone—Anaphylactic shock—Methotrexate—stomach cancer	0.00507	0.00507	CcSEcCtD
Metaxalone—Hypersensitivity—Capecitabine—stomach cancer	0.00502	0.00502	CcSEcCtD
Metaxalone—Pruritus—Docetaxel—stomach cancer	0.00498	0.00498	CcSEcCtD
Metaxalone—Pruritus—Capecitabine—stomach cancer	0.00482	0.00482	CcSEcCtD
Metaxalone—Leukopenia—Doxorubicin—stomach cancer	0.00482	0.00482	CcSEcCtD
Metaxalone—Anaphylactic shock—Epirubicin—stomach cancer	0.00474	0.00474	CcSEcCtD
Metaxalone—Dizziness—Docetaxel—stomach cancer	0.00465	0.00465	CcSEcCtD
Metaxalone—Somnolence—Methotrexate—stomach cancer	0.00451	0.00451	CcSEcCtD
Metaxalone—Dizziness—Capecitabine—stomach cancer	0.0045	0.0045	CcSEcCtD
Metaxalone—Vomiting—Docetaxel—stomach cancer	0.00447	0.00447	CcSEcCtD
Metaxalone—Rash—Docetaxel—stomach cancer	0.00444	0.00444	CcSEcCtD
Metaxalone—Dermatitis—Docetaxel—stomach cancer	0.00443	0.00443	CcSEcCtD
Metaxalone—Headache—Docetaxel—stomach cancer	0.00441	0.00441	CcSEcCtD
Metaxalone—Anaphylactic shock—Doxorubicin—stomach cancer	0.00439	0.00439	CcSEcCtD
Metaxalone—Vomiting—Capecitabine—stomach cancer	0.00433	0.00433	CcSEcCtD
Metaxalone—Rash—Capecitabine—stomach cancer	0.00429	0.00429	CcSEcCtD
Metaxalone—Dermatitis—Capecitabine—stomach cancer	0.00429	0.00429	CcSEcCtD
Metaxalone—Headache—Capecitabine—stomach cancer	0.00427	0.00427	CcSEcCtD
Metaxalone—Somnolence—Epirubicin—stomach cancer	0.00422	0.00422	CcSEcCtD
Metaxalone—Nausea—Docetaxel—stomach cancer	0.00418	0.00418	CcSEcCtD
Metaxalone—Nausea—Capecitabine—stomach cancer	0.00405	0.00405	CcSEcCtD
Metaxalone—Somnolence—Doxorubicin—stomach cancer	0.0039	0.0039	CcSEcCtD
Metaxalone—Hypersensitivity—Methotrexate—stomach cancer	0.00374	0.00374	CcSEcCtD
Metaxalone—Pruritus—Methotrexate—stomach cancer	0.00359	0.00359	CcSEcCtD
Metaxalone—Hypersensitivity—Epirubicin—stomach cancer	0.0035	0.0035	CcSEcCtD
Metaxalone—Pruritus—Epirubicin—stomach cancer	0.00336	0.00336	CcSEcCtD
Metaxalone—Dizziness—Methotrexate—stomach cancer	0.00335	0.00335	CcSEcCtD
Metaxalone—Hypersensitivity—Doxorubicin—stomach cancer	0.00323	0.00323	CcSEcCtD
Metaxalone—Vomiting—Methotrexate—stomach cancer	0.00322	0.00322	CcSEcCtD
Metaxalone—Rash—Methotrexate—stomach cancer	0.0032	0.0032	CcSEcCtD
Metaxalone—Dermatitis—Methotrexate—stomach cancer	0.00319	0.00319	CcSEcCtD
Metaxalone—Headache—Methotrexate—stomach cancer	0.00318	0.00318	CcSEcCtD
Metaxalone—Dizziness—Epirubicin—stomach cancer	0.00314	0.00314	CcSEcCtD
Metaxalone—Pruritus—Doxorubicin—stomach cancer	0.00311	0.00311	CcSEcCtD
Metaxalone—Vomiting—Epirubicin—stomach cancer	0.00302	0.00302	CcSEcCtD
Metaxalone—Nausea—Methotrexate—stomach cancer	0.00301	0.00301	CcSEcCtD
Metaxalone—Rash—Epirubicin—stomach cancer	0.00299	0.00299	CcSEcCtD
Metaxalone—Dermatitis—Epirubicin—stomach cancer	0.00299	0.00299	CcSEcCtD
Metaxalone—Headache—Epirubicin—stomach cancer	0.00297	0.00297	CcSEcCtD
Metaxalone—Dizziness—Doxorubicin—stomach cancer	0.0029	0.0029	CcSEcCtD
Metaxalone—Nausea—Epirubicin—stomach cancer	0.00282	0.00282	CcSEcCtD
Metaxalone—Vomiting—Doxorubicin—stomach cancer	0.00279	0.00279	CcSEcCtD
Metaxalone—Rash—Doxorubicin—stomach cancer	0.00277	0.00277	CcSEcCtD
Metaxalone—Dermatitis—Doxorubicin—stomach cancer	0.00277	0.00277	CcSEcCtD
Metaxalone—Headache—Doxorubicin—stomach cancer	0.00275	0.00275	CcSEcCtD
Metaxalone—Nausea—Doxorubicin—stomach cancer	0.00261	0.00261	CcSEcCtD
